Corcept Therapeutics Inc (CORT)
22.68
-0.32
(-1.39%)
USD |
NASDAQ |
Apr 18, 16:00
22.66
-0.02
(-0.07%)
After-Hours: 20:00
Corcept Therapeutics Cash from Operations (TTM): 127.04M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 127.04M |
| September 30, 2023 | 154.54M |
| June 30, 2023 | 135.28M |
| March 31, 2023 | 111.03M |
| December 31, 2022 | 120.32M |
| September 30, 2022 | 136.36M |
| June 30, 2022 | 151.42M |
| March 31, 2022 | 177.72M |
| December 31, 2021 | 167.89M |
| September 30, 2021 | 153.54M |
| June 30, 2021 | 135.28M |
| March 31, 2021 | 144.12M |
| December 31, 2020 | 151.97M |
| September 30, 2020 | 165.35M |
| June 30, 2020 | 173.34M |
| March 31, 2020 | 145.70M |
| December 31, 2019 | 136.12M |
| September 30, 2019 | 109.18M |
| June 30, 2019 | 115.26M |
| March 31, 2019 | 104.92M |
| December 31, 2018 | 115.66M |
| September 30, 2018 | 119.03M |
| June 30, 2018 | 85.45M |
| March 31, 2018 | 85.80M |
| December 31, 2017 | 60.94M |
| Date | Value |
|---|---|
| September 30, 2017 | 40.62M |
| June 30, 2017 | 38.63M |
| March 31, 2017 | 24.66M |
| December 31, 2016 | 18.39M |
| September 30, 2016 | 17.98M |
| June 30, 2016 | 9.933M |
| March 31, 2016 | 8.204M |
| December 31, 2015 | 3.13M |
| September 30, 2015 | -2.436M |
| June 30, 2015 | -9.248M |
| March 31, 2015 | -18.09M |
| December 31, 2014 | -27.38M |
| September 30, 2014 | -33.64M |
| June 30, 2014 | -36.31M |
| March 31, 2014 | -36.56M |
| December 31, 2013 | -37.06M |
| September 30, 2013 | -38.13M |
| June 30, 2013 | -38.76M |
| March 31, 2013 | -37.42M |
| December 31, 2012 | -36.02M |
| September 30, 2012 | -33.57M |
| June 30, 2012 | -30.95M |
| March 31, 2012 | -30.26M |
| December 31, 2011 | -27.40M |
| September 30, 2011 | -26.56M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
109.18M
Minimum
Sep 2019
177.72M
Maximum
Mar 2022
142.71M
Average
144.12M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
| Ultragenyx Pharmaceutical Inc | -474.81M |
| Alnylam Pharmaceuticals Inc | 104.16M |
| Catalyst Pharmaceuticals Inc | 143.60M |
| United Therapeutics Corp | 978.00M |
| XOMA Corp | -18.16M |